CENCORA
LIVE

Serial Number

97765090

Owner

AmerisourceBergen Corporation

Attorney

Anita B. Polott

Filing Date

Jan 23, 2023

Add to watchlist:

No watchlists yet
View on USPTO

CENCORA Trademark

Serial Number: 97765090

CENCORA is a trademark filed by AmerisourceBergen Corporation on January 23, 2023. The trademark is classified under Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

AmerisourceBergen Corporation (57 trademarks)

1 West First Avenue
Conshohocken, PA 19428

Entity Type: 03

CENCORA, INC.

1 WEST FIRST AVENUE
CONSHOHOCKEN, PA 19428

Entity Type: 03

Trademark Details

Filing Date

January 23, 2023

Registration Date

Not Registered

Published for Opposition

June 11, 2024

Goods & Services

Medical analysis services; Medical analysis services, namely, analyzing and reporting in the field of human disease treatment; providing a secured-access internet website for medical professionals and medical patients featuring medical information and analysis of patient data in the field of oncology care practices, namely, the specific diagnosis, line of therapy, stage of disease and regimen; providing clinical and home health care services, namely, providing information relating to therapeutic properties of pharmaceuticals; providing counseling to patients in the field of administration of medications; providing a secured-access internet website for medical professionals and medical patients featuring medical information and analysis of patient data in the field of oncology care practices, namely, the specific diagnosis, line of therapy, stage of disease and regimen; providing clinical and home health care services; providing clinical and home health care services, namely, providing information relating to therapeutic properties of pharmaceuticals; providing counseling to patients in the field of administration of medications; providing medical provider and care information; providing wellness programs for disease treatment and management featuring patient-centered incentives for compliance with physician-directed educational, medication therapy, and home care programs; information services for the pharmaceutical and medical sectors; counseling services related to workplace and personnel health; healthcare services; services of information on medical substances; analysing and reporting of discussions about human disease treatment; administration and management of sophisticated pharmaceutical therapies; providing a website featuring customisable information and analysis about legislative regulatory developments in the field of healthcare; telehealth services, namely, healthcare services provided via telecommunication in the nature of remote monitoring of data indicative of the health or condition of a patient for medical treatment purposes; telehealth services, namely, providing patients with health information relating to their medical condition; beauty and health care advice services; providing nursing services to others on behalf of pharmaceutical and biotechnology companies; Providing information on health and nutrition in the field of animal management; consulting services in the field of animal husbandry, medical and healthcare management, namely, medical research, development, analysis and identification of processes to efficiently raise individual animals; providing a website featuring information to retail customers of pharmacies over a global computer network with regard to health, wellness and pharmacy news; providing information, news and commentary in the field of current events relating to the healthcare industry and healthcare legislation and regulation; providing on-line information, news and commentary in the field of health and wellness relating to healthy diets and activities for male and female infants, children, teenagers, adults and seniors and to illnesses and treatments affecting them; pharmaceutical consultation; providing medical information

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 4, 2026 EXRA
SOU EXTENSION 3 GRANTED
Feb 3, 2026 EX3G
SOU EXTENSION 3 FILED
Feb 3, 2026 EXT3
SOU TEAS EXTENSION RECEIVED
Feb 3, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 5, 2025 EXRA
SOU EXTENSION 2 GRANTED
Aug 4, 2025 EX2G
SOU EXTENSION 2 FILED
Aug 4, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Aug 4, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 5, 2025 EXRA
SOU EXTENSION 1 GRANTED
Feb 5, 2025 EX1G
SOU EXTENSION 1 FILED
Feb 4, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 4, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 6, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 11, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jun 11, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 22, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 9, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
May 9, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 9, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
May 9, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 9, 2024 CNEA
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Apr 18, 2024 AMPX
TEAS VOLUNTARY AMENDMENT RECEIVED
Apr 18, 2024 PARI
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 18, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 18, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 18, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jan 16, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jan 16, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 24, 2023 GNRN
NON-FINAL ACTION E-MAILED
Oct 24, 2023 GNRT
NON-FINAL ACTION WRITTEN
Oct 24, 2023 CNRT
ASSIGNED TO EXAMINER
Oct 19, 2023 DOCK
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Oct 18, 2023 ASGN
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 13, 2023 NWOS
NEW APPLICATION ENTERED
Jan 26, 2023 NWAP